RIGVIR® is a prescription medicine approved for the treatment of melanoma, local therapy of the skin and subcutaneous metastases of melanoma and the prevention of relapses of metastases after surgery. RIGVIR® is also an immunomodulator.

In clinical practice RIGVIR® is also used for other types of cancer, based on the individual recommendations of physicians.



                                                SUMMARY OF PRODUCT CHARACTERISTICS